Is there a Single “Best” Platform or will it be “Fit to Purpose”?

Time: 2:00 pm
day: Pre-Conference Focus Day


  • Analysing the advantages, disadvantages and comparisons of the DNA, Peptide,
  • RNA, and Virus-based and other novel vaccine platforms
  • Harmonisation of clinical outcomes and imune correlates
  • Considering if we can we get better at predictive animal models?
  • Questioning what other signals we need to provide to the immune system, either
    built into the vaccine or given concomitantly (checkpoints, costims, cytokines,
    innate immunity boosters, etc.)